ARAY
Price
$0.92
Change
-$0.05 (-5.15%)
Updated
Nov 19, 01:29 PM (EDT)
Capitalization
110.14M
77 days until earnings call
Intraday BUY SELL Signals
NVST
Price
$18.84
Change
-$0.29 (-1.52%)
Updated
Nov 19, 03:54 PM (EDT)
Capitalization
3.15B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARAY vs NVST

Header iconARAY vs NVST Comparison
Open Charts ARAY vs NVSTBanner chart's image
Accuray
Price$0.92
Change-$0.05 (-5.15%)
Volume$1.13K
Capitalization110.14M
Envista Holdings
Price$18.84
Change-$0.29 (-1.52%)
Volume$2.69K
Capitalization3.15B
ARAY vs NVST Comparison Chart in %
ARAY
Daily Signal:
Gain/Loss:
NVST
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARAY vs. NVST commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and NVST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (ARAY: $0.97 vs. NVST: $19.13)
Brand notoriety: ARAY and NVST are both not notable
ARAY represents the Medical/Nursing Services, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ARAY: 293% vs. NVST: 72%
Market capitalization -- ARAY: $110.14M vs. NVST: $3.15B
ARAY [@Medical/Nursing Services] is valued at $110.14M. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.15B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $226.05B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.83B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 1 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 1 green, 4 red.
According to our system of comparison, NVST is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 3 TA indicator(s) are bullish while NVST’s TA Score has 3 bullish TA indicator(s).

  • ARAY’s TA Score: 3 bullish, 6 bearish.
  • NVST’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NVST is a better buy in the short-term than ARAY.

Price Growth

ARAY (@Medical/Nursing Services) experienced а -16.94% price change this week, while NVST (@Pharmaceuticals: Other) price change was -5.34% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.85%. For the same industry, the average monthly price growth was -7.89%, and the average quarterly price growth was +10.85%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.03%. For the same industry, the average monthly price growth was -0.04%, and the average quarterly price growth was +8.70%.

Reported Earning Dates

ARAY is expected to report earnings on Feb 04, 2026.

NVST is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.85% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-2.03% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.15B) has a higher market cap than ARAY($110M). NVST YTD gains are higher at: -0.829 vs. ARAY (-50.919). NVST has higher annual earnings (EBITDA): 341M vs. ARAY (20.2M). NVST has more cash in the bank: 1.13B vs. ARAY (57.4M). ARAY has less debt than NVST: ARAY (176M) vs NVST (1.6B). NVST has higher revenues than ARAY: NVST (2.62B) vs ARAY (459M).
ARAYNVSTARAY / NVST
Capitalization110M3.15B3%
EBITDA20.2M341M6%
Gain YTD-50.919-0.8296,139%
P/E RatioN/A212.33-
Revenue459M2.62B18%
Total Cash57.4M1.13B5%
Total Debt176M1.6B11%
FUNDAMENTALS RATINGS
ARAY vs NVST: Fundamental Ratings
ARAY
NVST
OUTLOOK RATING
1..100
5378
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8887
PRICE GROWTH RATING
1..100
9359
P/E GROWTH RATING
1..100
344
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (84) in the null industry is in the same range as ARAY (85) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

NVST's SMR Rating (87) in the null industry is in the same range as ARAY (88) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

NVST's Price Growth Rating (59) in the null industry is somewhat better than the same rating for ARAY (93) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than ARAY’s over the last 12 months.

NVST's P/E Growth Rating (4) in the null industry is in the same range as ARAY (34) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYNVST
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signal:
Gain/Loss:
NVST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSLX16.370.06
+0.37%
NYLI Fiera SMID Growth Class C
FIVOX13.70N/A
N/A
Fidelity Advisor International Value C
TWCUX104.30N/A
N/A
American Century Ultra® Inv
BIVSX17.17N/A
N/A
Invenomic Super Institutional
PFPGX30.08-0.36
-1.18%
Parnassus Growth Equity Institutional

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with QDEL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-2.36%
QDEL - ARAY
46%
Loosely correlated
+0.81%
ILMN - ARAY
41%
Loosely correlated
+1.57%
A - ARAY
41%
Loosely correlated
-0.47%
ICUI - ARAY
40%
Loosely correlated
-0.36%
NVST - ARAY
39%
Loosely correlated
+0.10%
More